CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Next-Generation Sequencing: Analysis of Gastrointestinal Cancers

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 106
Year: 2018
COI code: IPMCMED03_029
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Next-Generation Sequencing: Analysis of Gastrointestinal Cancers

Niloofar Agharezaee - Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Flora Forouzesh - Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Abstract:

Introduction: Gastrointestinal cancers including colorectal, liver, gastric and esophageal cancers are an increasing health problem throughout the world. Next Generation Sequencing (NGS) of cancer tissues is progressively being carried out to identify somatic genomic alterations that may guide physicians to make therapeutic results. Treating tumors based on mutational profiles has shown to be a feasible option in multiple solid tumor studies, and this approach is being progressively incorporated in clinical practice. Recent application of large-scale NGS technology to gastrointestinal cancer has helped better define the complex genomic landscape of these cancers. NGS technologies in human diseases to encourage human social insurance and personalized medicine. The aim of this study was the review of the use of NGS in the analysis of gastrointestinal cancers.Methods: We reviewed 10 articles from 2015 to 2018 in this study. The articles were searched from NCBI, PubMed, and Google Scholar.Results: A single tissue biopsy may not reflect complete genomic architecture due to the heterogeneous nature of tumors. Circulating tumor DNA (ctDNA) analysis is a robust noninvasive method to detect and monitor genomic alterations in blood in real time. Although ctDNA NGS analysis is becoming increasingly available commercially, there is the relative paucity of data regarding the extent of concordance between tumor tissue genomics and peripheral blood ctDNA, as well as regarding their respective roles in the context of overall patient management. Conclusion: As the cost of NGS continues to decline, in the near future whole genome sequencing, RNA sequencing and proteomics may become relatively predictable, adding further to the complexity of data explanation and implementation for equally academic and community oncologists. Recent NGS studies undoubtedly have provided a wealth of data that has better characterized the genomic landscape of gastrointestinal cancer.

Keywords:

Next generation sequencing, Personalized Medicine, Gastrointestinal Cancer

Perma Link

https://www.civilica.com/Paper-IPMCMED03-IPMCMED03_029.html
COI code: IPMCMED03_029

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Agharezaee, Niloofar & Flora Forouzesh, 2018, Next-Generation Sequencing: Analysis of Gastrointestinal Cancers, Third International Private Medical Congress of Iran, تهران, دانشگاه علوم پزشكي بقيه الله(عج), https://www.civilica.com/Paper-IPMCMED03-IPMCMED03_029.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Agharezaee, Niloofar & Flora Forouzesh, 2018)
Second and more: (Agharezaee & Forouzesh, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.